Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
measles, mumps, and rubella vaccine
- Development stage
- Approved
- Lead developer
- Merck
- Modality
- Vaccines & Immunotherapeutics
- Administration
- Subcutaneous, Intramuscular
01
Overview
The measles, mumps, and rubella (MMR) vaccine is a live-attenuated biologic vaccine used to provide active immunization against measles, mumps, and rubella infections. It is a combination product containing live attenuated strains of the three viruses: typically the Enders' attenuated Edmonston strain for measles, the Jeryl Lynn strain for mumps, and the Wistar RA 27/3 strain for rubella. The vaccine works by stimulating the human immune system to produce both humoral (antibody) and cellular immune responses against these pathogens. It is widely administered as part of standard pediatric immunization schedules. In specific clinical contexts, such as a Phase 4 study sponsored by Children's Mercy Hospital Kansas City, the vaccine is being evaluated for safety and efficacy in specialized populations like pediatric heart transplant recipients.
- Brand names
- M-M-R IIPriorixM-M-R-VaxPro
- Other names
- MMR vaccinemeasles, mumps, and rubella virus vaccine livemeasles, mumps, and rubella vaccine (live)
Beyond the preview
Go deeper on measles, mumps, and rubella vaccine.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on measles, mumps, and rubella vaccine.